2004
DOI: 10.1016/j.jcf.2004.01.005
|View full text |Cite
|
Sign up to set email alerts
|

Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults

Abstract: BCC infection is associated with an accelerated decline in pulmonary function and BMI. Infection with a single B. cenocepacia strain was associated with a more rapid decline in lung function than those infected with either B. multivorans or P. aeruginosa.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
95
1
3

Year Published

2007
2007
2020
2020

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 124 publications
(99 citation statements)
references
References 36 publications
0
95
1
3
Order By: Relevance
“…However, most of these studies have focused on clinical outcomes in patients with epidemic and virulent genotypes, such as the B. cenocepacia ET-12 strain (33). Our results show that patients with chronic infections had lower lung func- Other studies have also suggested that the clinical outcomes for patients infected with B. cepacia complex are species dependent and that the host-pathogen interaction is also likely to play a role in virulence and clinical impacts (14,33,34). Jones and colleagues (33) reported excess mortality and accelerated clinical decline in patients with the ET-12 strain, whereas our study, which was dominated by sporadic B. cepacia complex infection, did not find increased rates of mortality or the need for lung transplantation.…”
Section: Discussionmentioning
confidence: 51%
“…However, most of these studies have focused on clinical outcomes in patients with epidemic and virulent genotypes, such as the B. cenocepacia ET-12 strain (33). Our results show that patients with chronic infections had lower lung func- Other studies have also suggested that the clinical outcomes for patients infected with B. cepacia complex are species dependent and that the host-pathogen interaction is also likely to play a role in virulence and clinical impacts (14,33,34). Jones and colleagues (33) reported excess mortality and accelerated clinical decline in patients with the ET-12 strain, whereas our study, which was dominated by sporadic B. cepacia complex infection, did not find increased rates of mortality or the need for lung transplantation.…”
Section: Discussionmentioning
confidence: 51%
“…The majority of BCC infections in CF patients (typically at least 70 %) are caused by Burkholderia cenocepacia and Burkholderia multivorans, and whilst B. cenocepacia previously accounted for the majority of cases, in recent years the incidence of B. multivorans infection has surpassed that of B. cenocepacia (Govan et al, 2007;LiPuma, 2010). B. cenocepacia typically has a greater impact on patient survival than B. multivorans (Courtney et al, 2004;Jones et al, 2004), although certain strains of B.…”
Section: Introductionmentioning
confidence: 99%
“…Burkholderia cenocepacia, a member of the Bcc, is one of the species most often recovered from CF patients worldwide and is also associated with the most severe infections (Brisse et al, 2004;LiPuma, 2005;Manno et al, 2004;Reik et al, 2005; Speert et al, 2002). Furthermore, B. cenocepacia infections in CF patients are associated with an accelerated decline in lung function as compared to other CF-related pathogens such as Pseudomonas aeruginosa (Courtney et al, 2004;Jones et al, 2004). The treatment of infection is difficult because this bacterium is multi-drug resistant (Zhou et al, 2007) and can be transmitted from person to person (Govan et al, 1993;LiPuma et al, 1990;Smith et al, 1993).…”
Section: Introductionmentioning
confidence: 99%